RNXT
RenovoRx Inc
1.60$
-0.6%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +358.1% | +114.2% | -37.0% | -10.5% | +136.6% | +61.5% | – | |
| – | – | – | – | – | – | – | +61.7% | -65.1% | -47.2% | +200.0% | +70.2% | – | |
| – | – | – | – | – | – | – | +162.1% | -21.1% | -1.4% | +128.1% | +59.9% | – | |
| – | -52.4% | +62.2% | +22.7% | +7.0% | -4.5% | +4.2% | -13.2% | +18.2% | -10.9% | -18.2% | -2.3% | – | |
| – | -26.0% | +21.7% | +22.4% | -21.0% | -6.7% | +42.9% | -3.1% | +13.5% | -9.1% | +73.1% | +7.2% | – | |
| – | -40.4% | +39.3% | +22.5% | -6.8% | -5.4% | +20.1% | -8.2% | +15.8% | +9.4% | +5.8% | +0.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.